By Adam Bonislawski
Thermo Fisher Scientific and Intrinsic Bioprobes announced this week an agreement to develop and market a method for the detection of parathyroid hormone, or PTH, based on IBI's mass spectrometric immunoassay platform.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.
The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.